<DOC>
	<DOCNO>NCT00738517</DOCNO>
	<brief_summary>The purpose study investigate , immunoadsorption autoantibody subsequent substitution immunoglobulin able improve cardiac function patient heart failure myocardial infarction presence cardiac autoantibody .</brief_summary>
	<brief_title>Immunoadsorption Immunoglobulin Substitution Heart Failure After Myocardial Infarction</brief_title>
	<detailed_description>Heart failure due coronary heart disease ( CHD ) remain one frequent cause death . Left-ventricular ejection fraction &lt; 30 % associate 5-year mortality &gt; 70 % . Therefore , new strategy therapies towards treatment heart failure need . Heart failure due leave ventricular dysfunction develop CHD beyond area myocardial infarction . Some patient develop myocardial autoantibody , show exert negative inotropic effect . Their elimination immunoadsorption show improve left ventricular function dilatative cardiomyopathy . Immunoglobulins substitute minimize infection risk level , show effect cardiac function . This intervention might also ameliorate cardiac function patient heart failure due origin . This study therefore aim evaluate effect immunoadsorption subsequent immunoglobulin substitution .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>heart failure know coronary heart disease / post myocardial infarction complete treatment coronary heart disease ( know hemodynamically effective stenosis coronary vessel ) evidence scar myocardial tissue lowdose stress echocardiography myocardial scintigraphy MRI evidence hypocontractile myocardium echocardiography MRI outside infarction area least 3 month without acute coronary syndrome coronary intervention leftventricular ejection fraction echocardiography &lt; 45 % detection least one myocardial autoantibody ( e.g . antiß1receptor , antiTnI , antiKchIP2 ) serum dyspnea exertion equivalent NYHA II NYHA IV write informed consent patient heart failure due cardiac disease ( e.g . dilatative cardiomyopathy without evidence CHD , primary valve defect &gt; II° , toxic cardiomyopathy ) active infection pregnancy malign tumor disease secondary disease life expectancy &lt; 1 year refusal patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>heart failure</keyword>
	<keyword>coronary heart disease</keyword>
	<keyword>autoantibody</keyword>
	<keyword>immunoadsorption</keyword>
	<keyword>immunoglobulin substitution</keyword>
</DOC>